SecBot SecBot
Insider Cluster (2 insiders) ·Filed Feb 27, 2026

JAZZ

Jazz Pharmaceuticals plc
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $801K total
Actionable Insight • Neutral

The open-market sale by a director is modest in size and not unusual ahead of earnings or corporate events, but the lack of buying or broader executive participation limits negative signal. Monitor for additional selling or news catalysts.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
JAZZ ▲ +25.61% at T+60d
NEUTRAL call +25.61% · α vs SPY +16.22% · entry $189.00 → $237.41
Entry = T+0 close
Feb 26, 2026
via day close
T+1d
+0.69%
call +0.69% · α +0.63%
$190.30
settled 8mo ago
T+5d
-4.11%
call -4.11% · α -2.13%
$181.23
settled 8mo ago
T+20d
-3.42%
call -3.42% · α +4.14%
$182.54
settled 7mo ago
T+60d
+25.61%
call +25.61% · α +16.22%
$237.41
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

A recent insider trading cluster at Jazz Pharmaceuticals includes a significant open-market sale by director Bruce Cozadd totaling $588K and a large tax withholding share surrender by EVP Neena Patil worth $943K. The sale represents modest insider selling, while the tax withholding is a non-cash, routine transaction related to vesting equity.

Key Financial Metrics

Direction
selling
Total Value
$587.8K
Insiders
2

Key Facts

  • Director Bruce Cozadd sold 3,159 shares in the open market for $587,843 ($186.09 avg price).
  • EVP Neena Patil surrendered 5,000 shares to cover tax obligations on vesting equity, valued at $943,450.
  • Total cluster value: $1,531,293, with $587,843 in actual open-market selling.
  • Open-market selling represents ~0.005% of Jazz's $11.2B market cap — well below 0.1%, indicating minimal market impact.

Financial Impact

$587,843 in open-market selling by a director; $943,450 non-cash tax withholding transaction

insider ownershipshare count

Risk Factors

  • Perception of insider selling ahead of potential negative news, though volume is low.
  • Tax-related share surrenders can create short-term downward pressure if concentrated.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-JAZZ-1773090465374
28 reports for JAZZ
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+60▲ +22.04%Feb 24, 2026
Filters
Rows
Reports for JAZZ — sortable, filterable
TypeNow
Oct 19, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$213.76 $211.97▼ −0.84%▼ −1.36%$210.99 (−1.30%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 8, 2026
17d ago
144
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 6, 2026
19d ago
144
NEUTRAL ★ 2/10
$231.19 $222.45▼ −3.78%▼ −3.36%$210.99 (−8.74%)
Oct 1, 2026
24d ago
144
NEUTRAL ★ 2/10
$235.67 $236.04▲ +0.16%▼ −0.52%$210.99 (−10.47%)
Sep 15, 2026
5w ago
8-K
BULLISH ★ 6/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 14, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$245.80 $245.87▲ +0.03%▲ +0.47%$210.99 (−14.16%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$247.57 $246.81▲ +0.30%▼ −0.08%$210.99 (+14.78%)
Aug 31, 2026
7w ago
144
NEUTRAL ★ 2/10
$243.71 $245.57▲ +0.76%▲ +0.32%$210.99 (−13.43%)
Showing 10 of 28

US Market Status

Market Open — Closes in 5h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 9, 2026